Posts Tagged ‘innovation’

It’s been a long haul. But suddenly, we’re seeing a lot of optimism about anti-obesity medicines. Skeptics are yielding to stubborn facts about the impact of obesity on health. They are also yielding to good clinical data about the benefits of sound obesity care. So, too, are they seeing that newer generations of anti-obesity medicines […]

We knew that 2022 would bring more plants into the food we eat, with plant-based diets continuing to be a hot topic. This long-term trend would also bring some faddish ultra-processed foods along the way, we wrote. Six days into the new year, KFC and Chipotle are fulfilling the promise with new offerings of fake […]

Novo Nordisk has a problem. Yesterday its stock lost 16 billion dollars from its value. This is because the company is hitting some bumps in its journey through the uncharted territory of obesity care. For more than a decade now, Novo has been investing in a genuine effort to meet a need for better obesity […]

This is a time of great change in obesity care. Right now, semaglutide is on its way to becoming a blockbuster new drug. That’s because it can help people with obesity control their condition better – with more weight loss – than older anti-obesity medicines. But at the same time, new non-drug, non-systemic options with […]

Lancet this week published the biggest study yet of cagrilintide – evidence that we’re seeing success in progress with more options for anti-obesity medicines. In a commentary alongside this study, Kishore Gadde and David Allison call this promising news. They point to the advantage of having a new mechanism of action for treating obesity. Also, […]

Monday was quite an opening day for ObesityWeek 2021. Starting with the lived experience, the meeting then moved quickly into some serious science, clinical care, and policy discussions. But one of the most impressive sessions of the day gave us a “tour de force” of future options under development for obesity care. Our friend Mike […]

Day by day, the prospects for treating obesity are getting better. Late on Monday, detailed results from the longest study yet of tirzepatide came out in Lancet. This was a study using this new drug in people with type 2 diabetes, but the average BMI of these patients was 33. None of them had a […]

As rationalizations go, imagining huge health benefits from eating more plant-based diets is not terrible. Trisha Pasricha writes in the Washington Post that pneumonia, diverticulitis, diabetes, and cancers are linked to regularly eating meat. She even points to a study of COVID and plant-based diets to illustrate how beneficial such diets might be: “In a […]

It was an exciting possibility. At ObesityWeek 2019, Novartis scientist Laura Coleman presented fascinating results for an experimental drug, bimagumide, in obesity. In a phase 2 study, it yielded impressive improvements in body composition for people with obesity. It wasn’t just making people lose body fat. It helped them also gain muscle mass. Then, it […]

Healthy, green – plant-based – alternatives to food products from animals are generating quite a buzz right now. Restaurants are riding a wave of interest in this concept. With the planet burning and flooding everywhere we turn, wouldn’t it be nice if dining at HipCityVeg could help turn things around? New Forms of Food Multiplying […]